We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-10.63%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$24.1M
AUM Growth
-$8.82M
Cap. Flow
+$2.99M
Cap. Flow %
12.43%
Top 10 Hldgs %
100%
Holding
12
New
1
Increased
2
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.99M
2
BIS icon
ProShares UltraShort NASDAQ Biotechnology
BIS
+$1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 89%
2 Miscellaneous 11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$184B
$7.54M 31.33%
100,000
+25,000
+33% +$1.99M
TYME
2
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$4.63M 19.23%
2,075,000
– –
NVLN
3
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$3.5M 14.55%
1,000,000
– –
LAB icon
4
Standard BioTools
LAB
$252M
$2.4M 9.96%
410,500
– –
GSK icon
5
GSK
GSK
$101B
$1.95M 8.12%
40,000
– –
BIS icon
6
ProShares UltraShort NASDAQ Biotechnology
BIS
$1.77M
$1.59M 6.61%
9,375
+6,250
+200% +$1M
AMRN
7
Amarin Corp
AMRN
$297M
$1.35M 5.63%
22,500
– –
BIS icon
8
CALL
ProShares UltraShort NASDAQ Biotechnology
BIS
$1.77M
$1.06M 4.39%
+6,250
New +$1M
SEEL
9
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$41K 0.17%
1
– –
GILD icon
10
CALL
Gilead Sciences
GILD
$184B
– –
-60,000
Closed -$4.3M
MNKD icon
11
PUT
MannKind Corp
MNKD
$1.31B
– –
-50,000
Closed -$116K
FCSC
12
CALL
DELISTED
Fibrocell Science Inc.
FCSC
– –
-2,000
Closed -$6K

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q1 2018 Portfolio in Review

As of Q1 2018, Healthcare Value Capital held 12 positions worth $24.1M, down 27% from $32.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Healthcare Value Capital deployed $2.99M of net new capital in Q1 2018, opening 1 new position and adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 85% a quarter earlier, followed by Miscellaneous.

  • Healthcare Value Capital added most to Gilead Sciences in Q1 2018, an estimated $1.99M increase.
  • Healthcare Value Capital's ten largest holdings make up 100% of its $24.1M portfolio in Q1 2018.
  • Healthcare Value Capital opened 1 new position and closed 3 in Q1 2018.
  • Healthcare Value Capital's portfolio value fell 27% quarter-over-quarter to $24.1M.

Based on Healthcare Value Capital's 13F filing for Q1 2018, filed 27 Apr 2018.